Jul 29, 2024, 02:27
Leandro Jonata Oliveira: Would you recommend universal germline GT for patients with cancer?
Leandro Jonata Oliveira, Medical Oncologist at Grupo Oncoclinicas, shared a poll on X:
“Tapestry Study: screening using exome Sequencing identified 32% of HBOC and 56% of Lynch Syndrome carriers who did not meet NCCN criteria for genetic testing (GT).
In the scenario of unrestricted access to GT and couseling, would you recommend universal germline GT for patients with cancer?
- Yes
- Not
- Not yet
‘Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations published in JCO Precision Oncology’
Autors:
Source: Leandro Jonata Oliveira/X
Aleksander Sekulic
cancer
Cheryl L. Willman
Emily Gay
Eric W. Klee
exome Sequencing identifies
Jan B. Egan
Jennifer L. Anderson
Jennifer L. Kemppainen
Jessa S. Bidwell
Jolene M. Summer-Bolster
Katie L. Kunze
Konstantinos N. Lazaridis
Leandro Jonata Oliveira
Lorelei A. Bandel
Lynch Syndrome
Margaret A. Klint
Matthew J. Ferber
Michael A. Golafshar
Michelle L. Bublitz
N. Jewel Samadder
NCCN
Nicholas B. Larson
OncoDaily
Oncology
Richard J. Presutti
Robert A. Vierkant
Sebastian M. Armasu
T'Nita S. Walker
Tammy M. McAllister
Teresa M. Kruisselbrink
Vanda Lindpere
William V. Bobo